Pfizer Inc
NYSE: PFE
$26.21
+$0.38 (+1.5%)
Closing Price on November 29, 2024
PFE Articles
Short selling is among the most controversial investment practices and has been blamed for sharp sell-offs in the stocks of a number of large companies, especially financial firms. Governments in...
Published:
Last Updated:
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual...
Published:
According to Reuters, banks may be hard hit by the bankruptcy of General Growth (GGP) and future commercial real estate defaults. Reuters reports that VW may overtake Toyota (TM) as the No.1 car...
Published:
Last Updated:
According to Reuters, Obama must get Americans to spend now and save later to help the economy, and consumers are wary of spending. Reuters reports that the SEC will consider restricting short...
Published:
Last Updated:
According to The Wall Street Journal, large US companies held their R&D spending steady in the fourth quarter of last year even though in most cases their revenue fell. According to the paper,...
Published:
Last Updated:
At 842, the S&P is pushing near a 25% gains since it bottomed for the year-to-date at 677 on March 9th. The bank stocks continue an extraordinary run over that period. Citigroup (C) is up 120%...
Published:
Last Updated:
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target. There is roughly $150 billion in new equity investor capital that can be put to work...
Published:
Last Updated:
A large part of the money that was made by banks and investment banks from 2004 through most of 2007 was made from mergers and acquisitions. When the credit markets fell apart, the financing for...
Published:
Last Updated:
According to Reuters, Obama faces backlash due to AIG (AIG) compensation issues which could set bank his efforts to salvage the financial system. Reuters reports that Lehman will put two of its...
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) is stopping its Phase III clinical trial of Sutent early. This is generally a scare over adverse events, but not in this case. Sutent apparently has shown such a...
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) just got its long-term ratings downgraded by Moody’s. It is amazing that bond ratings agencies still get to operate in a business as usual manner, but they do. Long gone...
Published:
Last Updated:
These are the top pre-market analyst upgrades and positive calls we have seen from analysts this Tuesday morning: Big Lots (BIG) Raised to Buy at Soleil. Corning (GLW) Raised to Buy at Collins...
Published:
Last Updated:
Citigroup (C) Still fears of nationalization or a larger bailout. Falls to $1.15. from a 52-week high of $27.35. GE (GE) Market not comforted that GE’s financial services are is not in trouble....
Published:
Last Updated:
These are some of this morning’s top pre-market analyst upgrades and positive research calls from Wall Street this Thursday morning with over two hours until the market opens: Axsys Technologies...
Published:
Last Updated:
According to Reuters, the White House is finishing a bank rescue package , that involves investment by private equity. Reuters reports that a poll of analysts cut Q2 earnings forecasts. Reuters...
Published:
Last Updated: